Nuclear Medicine in Pediatric Neurology and Neurosurgery: Epilepsy and Brain Tumors

Seminars in Nuclear Medicine

Volumn 37, Issue 5, 2007, Pages 357-381

  Patil, Shekhar ^a   Biassoni, Lorenzo ^b   Borgwardt, Lise ^c  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 FLUOROETHYL) LEVO TYROSINE F 18; ALPHA METHYL LEVO TRYPTOPHAN C 11; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE RECEPTOR; CARBAMAZEPINE; CHOLINE C 11; CHOLINE F 168; ETHYLENE CYSTEINE DIMER TC 99M; FLUMAZENIL C 11; FLUORODEOXYGLUCOSE F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IODOAMINE IODINE 123; IOFETAMINE I 123; LEUCINE C 11; METHIONINE C 11; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; METIROSINE; PENTETREOTIDE IN 111; PHENYTOIN; RADIOPHARMACEUTICAL AGENT; TYROSINE C 11; TYROSINE F 18; UNCLASSIFIED DRUG; VALPROIC ACID;

BRAIN BLOOD FLOW; BRAIN MAPPING; BRAIN PERFUSION; BRAIN REGION; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; DRUG DOSE INCREASE; DRUG HALF LIFE; DRUG SOLUBILITY; ELECTROENCEPHALOGRAM; EPILEPSY; EPILEPTIC FOCUS; FOCAL EPILEPSY; HUMAN; INFANTILE SPASM; INFORMATION PROCESSING; LENNOX GASTAUT SYNDROME; LIPOPHILICITY; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; PEDIATRICS; POSITRON EMISSION TOMOGRAPHY; REVIEW; SENSITIVITY ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STURGE WEBER SYNDROME; TEMPORAL LOBE EPILEPSY; TREATMENT FAILURE; TREATMENT RESPONSE; TUBEROUS SCLEROSIS; TUMOR RECURRENCE;

BRAIN NEOPLASMS; CHILD; EPILEPSY; HUMANS; NEUROLOGY; NEUROSURGERY; NUCLEAR MEDICINE; PEDIATRICS;

EID: 34547858213     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2007.04.002     Document Type: Review

References (239)

1. Hauser W. Epilepsy: Frequency, Causes and Consequences (1990), Demos Press, New York
2. Berg A.T., Langfitt J., Shinnar S., et al. How long does it take for partial epilepsy to become intractable?. Neurology 60 (2003) 186-190
3. Engel Jr. J. Surgery for seizures. N Engl J Med 334 (1996) 647-652
4. Cross J.H. Epilepsy surgery in childhood. Epilepsia 43 suppl (2002) 65-70
5. Cross J.H., Jayakar P., Nordli D., et al. Proposed criteria for referral and evaluation of children for epilepsy surgery: Recommendations of the Subcommission for Pediatric Epilepsy Surgery. Epilepsia 47 (2006) 952-959
6. Scott R.C., King M.D., Gadian D.G., et al. Hippocampal abnormalities after prolonged febrile convulsion: A longitudinal MRI study. Brain 126 (2003) 2551-2557
7. Jackson G.D., Connelly A., Duncan J.S., et al. Detection of hippocampal pathology in intractable partial epilepsy: Increased sensitivity with quantitative magnetic resonance T2 relaxometry. Neurology 43 (1993) 1793-1799
8. Woermann F.G., Barker G.J., Birnie K.D., et al. Regional changes in hippocampal T2 relaxation and volume: A quantitative magnetic resonance imaging study of hippocampal sclerosis. J Neurol Neurosurg Psychiatry 65 (1998) 656-664
9. Pell G.S., Briellmann R.S., Waites A.B., et al. Voxel based relaxometry: A new approach for analysis of T2 relaxometry changes in epilepsy. Neuroimage 21 (2004) 707-713
10. Jutila L., Immonen A., Mervaala E., et al. Long-term outcome of temporal lobe epilepsy surgery: Analyses of 140 consecutive patients. J Neurol Neurosurg Psychiatry 73 (2002) 486-494
11. Lin J.J., Salamon N., Dutton R.A., et al. Three-dimensional preoperative maps of hippocampal atrophy predict surgical outcomes in temporal lobe epilepsy. Neurology 65 (2005) 1094-1097
12. Engel Jr. J. Chair Report of the ILAE classification core group. Epilepsia 47 (2006) 1558-1568
13. Henry T.R. Progress in epilepsy research: Functional neuroimaging with positron emission tomography. Epilepsia 37 (1996) 1141-1154
14. Henry T.R., and Pennell P.B. Neuropharmacological imaging in epilepsy with PET and SPECT. Quart J Nucl Med 42 (1998) 199-210
15. Cherry S.R., and Phelps M.E. Imaging brain function with positron emission tomography. In: Toga A.W., and Mazziotta J.C. (Eds). Brain Mapping-The Methods (1996), Academic Press, San Diego 191-222
16. Van Heertum R.L., Drocea C., Ichise M., et al. Single photon emission CT and positron emission tomography in the evaluation of neurology disease. Radiol Clin N Am 39 (2001) 1007-1033
17. Gaillard W.D., Fazilat S., White S., et al. Interictal blood flow and metabolism are uncoupled in temporal lobe cortex in patients with complex partial epilepsy. Neurology 45 (1995) 1841-1847
18. 99mTc]-HMPAO SPECT. Epilepsia 42 (2001) 1515-1522
19. Hougaard K., Oikawa T., Sveinsdottir E., et al. Regional cerebral blood flow in focal cortical epilepsy. Arch Neurol 33 (1976) 527-535
20. Engel Jr. J., Kuhl D.E., Phelps M.E., et al. Local cerebral metabolism during partial seizures. Neurology 33 (1983) 400-413
21. Li L.M., Fish D.R., Sisodiya S.M., et al. High resolution magnetic resonance imaging in adults with partial or secondary generalised epilepsy attending a tertiary referral unit. J Neurol Neurosurg Psychiatry 59 (1995) 84-87
22. Hill T.C., Holman L., Lovett R., et al. Initial experience with SPECT of the brain using N-isopropyl I-123 p-iodoamphetamine: Concise communication. J Nucl Med 23 (1982) 191-195
23. Lee B.I., Markand O.N., Siddiqui A.R., et al. Single photon emission computed tomography (SPECT) brain imaging using N,N,N′-trimethyl-N′-(2 hydroxy-3-methyl-5-123I-iodobenzyl)-1,3-propanediamine 2 HCl (HIPDM): Intractable complex partial seizures. Neurology 36 (1986) 1471-1477
24. Lee B.I., Markand O.N., Wellman H.N., et al. HIPDM single photon emission computed tomography brain imaging in partial onset secondarily generalized tonic-clonic seizures. Epilepsia 28 (1987) 305-311
25. 99mTc-labelled hexamethylpropyleneamine oxime photon emission scans in epilepsy. Lancet 2 (1985) 1436-1437
26. 99mTc-hexamethyl-propylene amine oxime (HM-PAO) single photon emission computed tomography (SPECT) in patients with focal epilepsy. Epilepsy Res 1 (1987) 134-138
27. Harvey A.S. SPECT in the presurgical evaluation of children with intractable partial seizures. In: Tuxhorn I., Holthausen H., and Boenigk H. (Eds). Paediatric Epilepsy Syndromes and their Surgical Treatment (1997), John Libbey, London 261-273
28. Warwick J.M. Imaging of brain function using SPECT. Metab Brain Dis 19 (2004) 113-123
29. Saha G.B., MacIntyre W.J., and Go R.T. Radiopharmaceuticals for brain imaging. Semin Nucl Med 24 (1994) 324-349
30. Grunwald F., Menzel C., Pavics L., et al. Ictal and interictal brain SPECT imaging in epilepsy using technetium-99m-ECD. J Nucl Med 35 (1994) 1896-1901
31. Lee D.S., Lee S.K., Kim Y.K., et al. Superiority of HMPAO ictal SPECT to ECD ictal SPECT in localizing the epileptogenic zone. Epilepsia 43 (2002) 263-269
32. 99mTc-HMPAO for peri-ictal SPECT: Qualitative and quantitative analysis. J Neurol Neurosurg Psychiatry 66 (1999) 331-339
33. Asenbaum S., Brucke T., Pirker W., et al. Imaging of cerebral blood flow with technetium-99m-HMPAO and technetium-99m-ECD: A comparison. J Nucl Med 39 (1998) 613-618
34. Smith B.J., Karvelis K.C., Cronan S., et al. Developing an effective program to complete ictal SPECT in the epilepsy monitoring unit. Epilepsy Res 33 (1999) 189-197
35. Van Paesschen W., Dupont P., Van Heerden B., et al. Self-injection ictal SPECT during partial seizures. Neurology 54 (2000) 1994-1997
36. Wintermark M., Sesay M., Barbier E., et al. Comparative overview of brain perfusion imaging techniques. J Neuroradiol 32 (2005) 294-314
37. Wintermark M., Sesay M., Barbier E., et al. Comparative overview of brain perfusion imaging techniques. Stroke 36 (2005) 83-99
38. Commission on Diagnostic Strategies. Recommendations for functional neuroimaging of persons with epilepsy. Epilepsia 41 (2000) 1350-1356
39. Devous M.D., Leroy R.F., and Homan R.W. Single photon emission computed tomography in epilepsy. Semin Nucl Med 20 (1990) 325-341
40. Duncan R. SPECT imaging in focal epilepsy. In: Duncan R. (Ed). SPECT Imaging of the Brain (1997), Kluwer, Dordrecht 43-68
41. Vehoeff N.P., Buell U., Costa D.C., et al. Basics and recommendations for brain SPECT. Task Group "Neurology" of the European Association of Nuclear Medicine. Nuklearmedizin 31 (1992) 114-131
42. Prince D.A., and Wilder B.J. Control mechanisms in cortical epileptogenic foci. "Surround" inhibition. Arch Neurol 16 (1967) 194-202
43. Lee S.K., Yun C.H., Oh J.B., et al. Intracranial ictal onset zone in non lesional lateral temporal lobe epilepsy on scalp ictal EEG. Neurology 61 (2003) 757-764
44. Williamson P.D., Thadani V.M., Darcey T.M., et al. Occipital lobe epilepsy: Clinical characteristics, seizure spread patterns, and results of surgery. Ann Neurol 31 (1992) 3-13
45. Williamson P.D., Boon P.A., Thadani V.M., et al. Parietal lobe epilepsy: Diagnostic considerations and results of surgery. Ann Neurol 31 (1992) 193-201
46. Noachtar S., Arnold S., Yousry T.A., et al. Ictal technetium-99m ethyl cysteinate dimer single-photon emission tomographic findings and propagation of epileptic seizure activity in patients with extratemporal epilepsies. Eur J Nucl Med 25 (1998) 166-172
47. So E.L. Integration of EEG, MRI and SPECT in localizing the seizure focus for epilepsy surgery. Epilepsia 41 suppl 3 (2000) s48-s54
48. Heiskala H., Launes J., Pihko H., et al. Brain perfusion SPECT in children with frequent fits. Brain Dev 15 (1993) 214-218
49. Bruggemann J.M., Som S.S., Lawson J.A., et al. Application of statistical parametric mapping to SPET in the assessment of intractable childhood epilepsy. Eur J Nucl Med Mol Imaging 31 (2004) 369-377
50. Lee J.D., Kim H.J., Lee B.I., et al. Evaluation of ictal brain SPET using statistical parametric mapping in temporal lobe epilepsy. Eur J Nucl Med 27 (2000) 1658-1665
51. Tae W.S., Joo E.Y., Kim J.H., et al. Cerebral perfusion changes in mesial temporal lobe epilepsy: SPM analysis of ictal and interictal SPECT. Neuroimage 24 (2005) 101-110
52. Muzik O., Chugani D.C., Juhasz C., et al. Statistical parametric mapping: Assessment of application in children. Neuroimage 12 (2000) 538-549
53. O'Brien T.J., So E.L., Mullan B.P., et al. Subtraction ictal SPECT co-registered to MRI improves clinical usefulness of SPECT in localizing the surgical seizure focus. Neurology 50 (1998) 445-454
54. O'Brien T.J., So E.L., Mullan B.P., et al. Subtraction SPECT co-registered to MRI improves postictal SPECT localization of seizure foci. Neurology 52 (1999) 137-146
55. O'Brien T.J., So E.L., Mullan B.P., et al. Subtraction peri-ictal SPECT is predictive of extratemporal epilepsy surgery outcome. Neurology 55 (2000) 1668-1677
56. O'Brien T.J., So E.L., Cascino G.D., et al. Subtraction SPECT coregistered to MRI in focal malformations of cortical development: Localization of the epileptogenic zone in epilepsy surgery candidates. Epilepsia 45 (2004) 367-376
57. Lawson J.A., O'Brien T.J., Bleasel A.F., et al. Evaluation of SPECT in the assessment and treatment of intractable childhood epilepsy. Neurology 55 (2000) 1391-1393
58. Chiron C., Vera P., Kaminska A., et al. Single-photon emission computed tomography: ictal perfusion in childhood epilepsies. Brain Dev 21 (1999) 444-446
59. Kaminska A., Chiron C., Ville D., et al. Ictal SPECT in children with epilepsy: Comparison with intracranial EEG and relation to postsurgical outcome. Brain 126 (2003) 248-260
60. Valenti M.P., Froelich S., Armspach J.P., et al. Contribution of SISCOM imaging in the presurgical evaluation of temporal lobe epilepsy related to dysembryoplastic neuroepithelial tumors. Epilepsia 43 (2002) 270-276
61. Vera P., Kaminska A., Cieuta C., et al. Use of subtraction ictal SPECT co-registered to MRI for optimizing the localization of seizure foci in children. J Nucl Med 40 (1999) 786-792
62. Chiron C., Vera P., Kaminska A., et al. Ictal SPECT in the epileptic child. Contribution of subtraction interictal images and superposition of with MRI. Rev Neurol 155 (1999) 477-481 (Paris)
63. Borgwardt L., Larsen H.J., Pedersen K., et al. Practical use and implementation of PET in children in a hospital PET centre. Eur J Nucl Med Mol Imaging 30 (2003) 1389-1397
64. Suhonen-Polvi H., Ruotsalainen U., Kinnala A., et al. FDG-PET in early infancy: Simplified quantification methods to measure cerebral glucose utilization. J Nucl Med 36 (1995) 1249-1254
65. Casse R., Rowe C.C., Newton M., et al. Positron emission tomography and epilepsy. Mol Imaging Biol 4 (2002) 338-351
66. O'Brien T.J., Hicks R.J., Ware R., et al. The utility of a 3-dimensional, large-field-of-view, sodium iodide crystal-based PET scanner in the presurgical evaluation of partial epilepsy. J Nucl Med 42 (2001) 1158-1165
67. O'Brien T.J., Newton M.R., Cook M.J., et al. Hippocampal atrophy is not a major determinant of regional hypometabolism in temporal lobe epilepsy. Epilepsia 38 (1997) 74-80
68. Foldvary N., Lee N., Hanson M.W., et al. Correlation of hippocampal neuronal density and FDG-PET in mesial temporal lobe epilepsy. Epilepsia 40 (1999) 26-29
69. Koepp M.J., and Woermann F.G. Imaging structure and function in refractory focal epilepsy. Lancet Neurol 4 (2005) 42-53
70. Sood S., and Chugani H.T. Functional neuroimaging in the preoperative evaluation of children with drug-resistant epilepsy. Childs Nervs Syst 22 (2006) 810-820
71. Theodore W.H., and Gaillard W.D. Positron emission tomography in neocortical epilepsies. In: Williamson P.D., Siegel A.M., Robert D.W., et al. (Eds). Advances in Neurology (2000), Lippincott Williams and Wilkins, Philadelphia 435-446
72. Hajek M., Antonini A., Leenders K.L., et al. Mesiobasal versus lateral temporal lobe epilepsy: Metabolic differences in the temporal lobe shown by interictal 18F-FDG positron emission tomography. Neurology 43 (1993) 79-86
73. Valk P.E., Laxer K.D., Barbero N.M., et al. High-resolution (2.6-mm) PET in partial complex epilepsy associated with mesial temporal sclerosis. Radiology 186 (1993) 55-58
74. Henry T.R., Mazziotta J.C., Engel Jr. J., et al. Quantifying interictal metabolic activity in human temporal lobe epilepsy. J Cereb Blood Flow Metab 10 (1990) 748-757
75. Arnold S., Schlaug G., Niemann H., et al. Topography of interictal glucose hypometabolism in unilateral mesiotemporal epilepsy. Neurology 46 (1996) 1422-1430
76. Gaillard W.D., White S., Malow B., et al. FDG-PET in children and adolescents with partial seizures: Role in epilepsy surgery evaluation. Epilepsy Res 20 (1995) 77-84
77. Juhasz C., Chugani D.C., Muzik O., et al. Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome. Neurology 26; 56 (2001) 1650-1658
78. Ollenberger G.P., Byrne A.J., Berlangieri S.U., et al. Assessment of the role of FDG-PET in the diagnosis and management of children with refractory epilepsy. Eur J Nucl Med Mol Imaging 32 (2005) 1311-1316
79. Joo E.Y., Hong S.B., Han H.J., et al. Postoperative alteration of cerebral glucose metabolism in mesial temporal lobe epilepsy. Brain 128 (2005) 1802-1810
80. Akimura T., Yeh H.S., Mantil J.C., et al. Cerebral metabolism of the remote area after epilepsy surgery. Neurol Med Chir 39 (1999) 16-25 (Tokyo)
81. Frey K.A. Positron emission tomography. In: Seigel G.J., Agranoff B.W., Albers R.W., and Molinoff P.B. (Eds). Basic Neurochemistry: Molecular, Cellular and Medical Aspects. (ed 5) (1994), Raven Press, New York 935-955
82. Henry T.R., Babb T.L., Engel Jr. J., et al. Hippocampal neuronal loss and regional hypometabolism in temporal lobe epilepsy. Ann Neurol 36 (1994) 925-927
83. Sackellares J.C., Siegel G.J., Abou-Khalil B.W., et al. Differences between lateral and mesial temporal metabolism interictally in epilepsy of mesial temporal origin. Neurology 40 (1990) 1420-1426
84. Engel Jr. J., Brown W.J., Kuhl D.E., et al. Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy. Ann Neurol 12 (1982) 518-528
85. Benifla M., Otsubo H., Ochi A., et al. Temporal lobe surgery for intractable epilepsy in children: An analysis of outcomes in 126 children. Neurosurgery 59 (2006) 1203-1213
86. Theodore W.H., Newmark M.E., Sato S., et al. [18F]fluorodeoxyglucose positron emission tomography in refractory complex partial seizures. Ann Neurol 14 (1983) 429-437
87. Blum D.E., Ehsan T., Dungan D., et al. Bilateral temporal hypometabolism in epilepsy. Epilepsia 39 (1998) 651-659
88. Casse R., Rowe C.C., Newton M.D., et al. Positron emission tomography and epilepsy. Mol Imag Biol 4 (2002) 338-351
89. Delbeke D., Lawrence S.K., Abou-Khalil B.W., et al. Postsurgical outcome of patients with uncontrolled complex partial seizures and temporal lobe hypometabolism on 18FDG-positron emission tomography. Invest Radiol 31 (1996) 261-266
90. 99mTc-HMPAO SPET in pediatric temporal lobe epilepsy: Quantitative analysis by statistical parametric mapping, statistical probabilistic anatomical map, and subtraction ictal SPET. Seizure 14 (2005) 213-220
91. Rowe C.C., Berkovic S.F., Austin M.C., et al. Patterns of postictal cerebral blood flow in temporal lobe epilepsy: Qualitative and quantitative analysis. Neurology 41 (1991) 1096-1103
92. Ho S.S., Berkovic S.F., McKay W.J., et al. Temporal lobe epilepsy subtypes: Differential patterns of cerebral perfusion on ictal SPECT. Epilepsia 37 (1996) 788-795
93. Ho S.S., Newton M.R., McIntosh A.M., et al. Perfusion patterns during temporal lobe seizures: relationship to surgical outcome. Brain 120 (1997) 1921-1928
94. Newton M.R., Berkovic S.F., Austin M.C., et al. Postictal switch in blood flow distribution and temporal lobe seizures. J Neurol Neurosurg Psychiatry 55 (1992) 891-894
95. Newton M.R., Berkovic S.F., Austin M.C., et al. Dystonia, clinical lateralization, and regional blood flow changes in temporal lobe seizures. Neurology 42 (1992) 371-377
96. Harvey A.S., Bowe J.M., Hopkins I.J., et al. Ictal 99mTc-HMPAO single photon emission computed tomography in children with temporal lobe epilepsy. Epilepsia 34 (1993) 869-877
97. Wyllie E., Comair Y.G., Kotagal P., et al. Seizure outcome after epilepsy surgery in children and adolescents. Ann Neurol 44 (1998) 740-748
98. Lee S.K., Lee S.Y., Kim K.K., et al. Surgical outcome and prognostic factors of cryptogenic neocortical epilepsy. Ann Neurol 58 (2005) 525-532
99. Hong K.S., Lee S.K., Kim J.Y., et al. Pre-surgical evaluation and surgical outcome of 41 patients with non-lesional neocortical epilepsy. Seizure 11 (2002) 184-192
100. Radtke R.A., Hanson M.W., Hoffman J.M., et al. Positron emission tomography: comparison of clinical utility in temporal and extratemporal lobe epilepsy. J Epilepsy 7 (1994) 27-33
101. Matheja P., Kuwert T., Ludemann P., et al. Temporal hypometabolism at the onset of cryptogenic temporal lobe epilepsy. Eur J Nucl Med 28 (2001) 625-632
102. Swartz B.W., Khonsari A., Vrown C., et al. Improved sensitivity of 18FDG-positron emission tomography scans in frontal and "frontal plus" epilepsy. Epilepsia 36 (1995) 388-395
103. Kim Y.K., Lee D.S., Lee S.K., et al. (18)F-FDG-PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis. J Nucl Med 43 (2002) 1167-1174
104. Henry T.R., Sutherling W.W., Engel Jr. J., et al. Interictal cerebral metabolism in partial epilepsies of neocortical origin. Epilepsy Res 10 (1991) 174-182
105. Lee S.K., Lee S.Y., Kim K.K., et al. Surgical outcome and prognostic factors of cryptogenic neocortical epilepsy. Ann Neurol 58 (2005) 525-532
106. Da Silva E.A., Chugani D.C., Muzik O., et al. Identification of frontal lobe epileptic foci in children using positron emission tomography. Epilepsia 38 (1997) 1198-1208
107. Kim D.W., Lee S.K., Yun C.H., et al. Parietal lobe epilepsy: The semiology, yield of diagnostic workup, and surgical outcome. Epilepsia 45 (2004) 641-649
108. Kun Lee S., Young Lee S., Kim D.W., et al. Occipital lobe epilepsy: Clinical characteristics, surgical outcome, and role of diagnostic modalities. Epilepsia 46 (2005) 688-695
109. Meltzer C.C., Adelson P.D., Brenner R.P., et al. Planned ictal FDG-PET imaging for localization of extratemporal epileptic foci. Epilepsia 41 (2000) 193-200
110. Engel Jr. J., Kuhl D.E., and Phelps M.E. Patterns of human local cerebral glucose metabolism during epileptic seizures. Science 218 (1982) 64-66
111. Bruehl C., Hagemann G., and Witte O.W. Uncoupling of blood flow and metabolism in focal epilepsy. Epilepsia 39 (1998) 1235-1242
112. Hwang S.I., Kim J.H., Park S.W., et al. Comparative analysis of MR imaging, positron emission tomography, and ictal single-photon emission CT in patients with neocortical epilepsy. Am J Neuroradiol 22 (2001) 937-946
113. Sturm J.W., Newton M.R., Chinvarun Y., et al. Ictal SPECT and interictal PET in the localization of occipital lobe epilepsy. Epilepsia 41 (2000) 463-466
114. Kim S.K., Lee D.S., Lee S.K., et al. Diagnostic performance of [18F]FDG-PET and ictal [99mTc]-HMPAO SPECT in occipital lobe epilepsy. Epilepsia 42 (2001) 1531-1540
115. Harvey A.S., Hopkins I.J., Bowe J.M., et al. Frontal lobe epilepsy: Clinical seizure characteristics and localization with ictal 99mTc-HMPAO SPECT. Neurology 43 (1993) 1966-1980
116. Wetjen N.M., Cascino G.D., Fessler A.J., et al. Subtraction ictal single-photon emission computed tomography coregistered to magnetic resonance imaging in evaluating the need for repeated epilepsy surgery. J Neurosurg 105 (2006) 71-76
117. Juhasz C., Chugani D.C., Padhye U.N., et al. Evaluation with alpha-[11C]methyl-L-tryptophan positron emission tomography for reoperation after failed epilepsy surgery. Epilepsia 45 (2004) 124-130
118. Asarnow R.F., and Lopresti C. Adaptive functioning in children receiving resective surgery for medically intractable infantile spasms. In: Tuxhorn I., Holthausen H., and Boenigk H. (Eds). Paediatric Epilepsy Syndromes and their Surgical Treatment (1997), John Libbey, London 526-536
119. Chugani H.T., Da Silva E., Chugani C., et al. PET in the diagnostic evaluation of children with focal epilepsy. In: Tuxhorn I., Holthausen H., and Boenigk H. (Eds). Paediatric Epilepsy Syndromes and their Surgical Treatment (1997), John Libbey, London 592-606
120. Chugani H.T., Shields W.D., Shewmon D.A., et al. Surgery for intractable infantile spasms: Neuroimaging perspectives. Epilepsia 34 (1993) 764-771
121. Chugani H.T., and Conti J.R. Etiologic classification of infantile spasms in 140 cases: Role of positron emission tomography. J Child Neurol 11 (1996) 44-48
122. Szelies B., Herholz K., Heiss W.D., et al. Hypometabolic cortical lesions in tuberous sclerosis with epilepsy: Demonstration by positron emission tomography. J Comput Assist Tomogr 7 (1983) 946-953
123. Asano E., Chugani D.C., Muzik O., et al. Multimodality imaging for improved detection of epileptogenic foci in tuberous sclerosis complex. Neurology 54 (2000) 1976-1984
124. Chugani D.C., Chugani H.T., Muzik O., et al. Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography. Ann Neurol 44 (1998) 858-866
125. Kagawa K., Chugani D.C., Asano E., et al. Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha-[11C]methyl-L-tryptophan positron emission tomography (PET). J Child Neurol 20 (2005) 429-438
126. Chandra P.S., Salamon N., Huang J., et al. FDG-PET/MRI coregistration and diffusion-tensor imaging distinguish epileptogenic tubers and cortex in patients with tuberous sclerosis complex: A preliminary report. Epilepsia 47 (2006) 1543-1549
127. Koh S., Jayakar P., Resnick T., et al. The localizing value of ictal SPECT in children with tuberous sclerosis complex and refractory partial epilepsy. Epileptic Disord 1 (1999) 41-46
128. Hammers A., Koepp M.J., Hurlemann R., et al. Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI. Brain 125 (2002) 2257-2271
129. Savic I, Thorell JO, Roland P: [11C]flumazenil positron emission tomography visualizes frontal epileptogenic regions. Epilepsia 36:1225-1232
130. Juhasz C., Chugani D.C., Muzik O., et al. Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy. Neurology 55 (2000) 825-835
131. Carstensen H., Juhler M., and Wagner A. [Central nervous system tumors in children]. Ugeskr Laeger 161 (1999) 2186-2191
132. Young H., Baum R., Cremerius U., et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: Review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer 35 (1999) 1773-1782
133. Pötter R., Czech T.H., Dieckmann I., et al. Tumors of the central nervous system. In: Voute P.A., Kalifa C., and Barrett A. (Eds). Cancer in Children. Clinical Management. (ed 4) (1998), Oxford University Press, New York 170-193
134. Schmiegelow M., Lassen S., Weber L., et al. Dosimetry and growth hormone deficiency following cranial irradiation of childhood brain tumors. Med Pediatr Oncol 33 (1999) 564-571
135. Schmiegelow M., Lassen S., Poulsen H.S., et al. Cranial radiotherapy of childhood brain tumours: Growth hormone deficiency and its relation to the biological effective dose of irradiation in a large population based study. Clin Endocrinol 53 (2000) 191-197 (Oxf)
136. Schmiegelow M., Lassen S., Poulsen H.S., et al. Gonadal status in male survivors following childhood brain tumors. J Clin Endocrinol Metab 86 (2001) 2446-2452
137. Reimers T.S., Ehrenfels S., Mortensen E.L., et al. Cognitive deficits in long-term survivors of childhood brain tumors: Identification of predictive factors. Med Pediatr Oncol 40 (2003) 26-34
138. Sonderkaer S., Schmiegelow M., Carstensen H., et al. Long-term neurological outcome of childhood brain tumors treated by surgery only. J Clin Oncol 21 (2003) 1347-1351
139. Benard F., Romsa J., and Hustinx R. Imaging gliomas with positron emission tomography and single-photon emission computed tomography. Semin Nucl Med 33 (2003) 148-162
140. Schlemmer H.P., Bachert P., Henze M., et al. Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy. Neuroradiology 44 (2002) 216-222
141. Di Chiro G., DeLaPaz R.L., Brooks R.A., et al. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology 32 (1982) 1323-1329
142. Borgwardt L., Hojgaard L., Carstensen H., et al. Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: A study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion. J Clin Oncol 23 (2005) 3030-3037
143. Utriainen M., Metsahonkala L., Salmi T.T., et al. Metabolic characterization of childhood brain tumors: Comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography. Cancer 95 (2002) 1376-1386
144. Hoffman J.M., Hanson M.W., Friedman H.S., et al. FDG-PET in pediatric posterior fossa brain tumors. J Comput Assist Tomogr 16 (1992) 62-68
145. Holthoff V.A., Herholz K., Berthold F., et al. In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment. Cancer 72 (1993) 1394-1403
146. Blasberg R.G. Prediction of brain tumor therapy response by PET. J Neurooncol 22 (1994) 281-286
147. Kim C.K., Alavi J.B., Alavi A., et al. New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose. J Neurooncol 10 (1991) 85-91
148. Di Chiro G., Brooks R.A., Patronas N.J., et al. Issues in the in vivo measurement of glucose metabolism of human central nervous system tumors. Ann Neurol 15 suppl (1984) S138-S146
149. Herholz K., Rudolf J., and Heiss W.D. FDG transport and phosphorylation in human gliomas measured with dynamic PET. J Neurooncol 12 (1992) 159-165
150. Mineura K., Yasuda T., Kowada M., et al. Positron emission tomographic evaluation of histological malignancy in gliomas using oxygen-15 and fluorine-18-fluorodeoxyglucose. Neurol Res 8 (1986) 164-168
151. Patronas N.J., Brooks R.A., DeLaPaz R.L., et al. Glycolytic rate (PET) and contrast enhancement (CT) in human cerebral gliomas. AJNR Am J Neuroradiol 4 (1983) 533-535
152. Hustinx R., and Alavi A. SPECT and PET imaging of brain tumors. Neuroimaging Clin N Am 9 (1999) 751-766
153. Thiel A., Pietrzyk U., Sturm V., et al. Enhanced accuracy in differential diagnosis of radiation necrosis by positron emission tomography-magnetic resonance imaging coregistration: Technical case report. Neurosurgery 46 (2000) 232-234
154. Molenkamp G., Riemann B., Kuwert T., et al. Monitoring tumor activity in low grade glioma of childhood. Klin Padiatr 210 (1998) 239-242
155. Kaplan A.M., Bandy D.J., Manwaring K.H., et al. Functional brain mapping using positron emission tomography scanning in preoperative neurosurgical planning for pediatric brain tumors. J Neurosurg 91 (1999) 797-803
156. Messing-Junger A.M., Floeth F.W., Pauleit D., et al. Multimodal target point assessment for stereotactic biopsy in children with diffuse bithalamic astrocytomas. Childs Nerv Syst 18 (2002) 445-449
157. Borgwardt L., Larsen H.J., Pedersen K., et al. Practical use and implementation of PET in children in a hospital PET centre. Eur J Nucl Med Mol Imaging 30 (2003) 1389-1397
158. Bruggers C.S., Friedman H.S., Fuller G.N., et al. Comparison of serial PET and MRI scans in a pediatric patient with a brainstem glioma. Med Pediatr Oncol 21 (1993) 301-306
159. Plowman P.N., Saunders C.A., and Maisey M. On the usefulness of brain PET scanning to the paediatric neuro-oncologist. Br J Neurosurg 11 (1997) 525-532
160. O'Tuama L.A., Phillips P.C., Strauss L.C., et al. Two-phase [11C]L-methionine PET in childhood brain tumors. Pediatr Neurol 6 (1990) 163-170
161. Wong T.Z., van der Westhuizen G.J., and Coleman R.E. Positron emission tomography imaging of brain tumors. Neuroimaging Clin N Am 12 (2002) 615-626
162. Di Chiro G., Oldfield E., Wright D.C., et al. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. AJR Am J Roentgenol 150 (1988) 189-197
163. Valk P.E., and Dillon W.P. Radiation injury of the brain. AJNR Am J Neuroradiol 12 (1991) 45-62
164. Valk P.E., Budinger T.F., Levin V.A., et al. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome. J Neurosurg 69 (1988) 830-838
165. Doyle W.K., Budinger T.F., Valk P.E., et al. Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography. J Comput Assist Tomogr 11 (1987) 563-570
166. Patronas N.J., Di Chiro G., Brooks R.A., et al. Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology 144 (1982) 885-889
167. Kim E.E., Chung S.K., Haynie T.P., et al. Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG-PET. Radiographics 12 (1992) 269-279
168. Deshmukh A., Scott J.A., Palmer E.L., et al. Impact of fluorodeoxyglucose positron emission tomography on the clinical management of patients with glioma. Clin Nucl Med 21 (1996) 720-725
169. Chao S.T., Suh J.H., Raja S., et al. The sensitivity and specificity of FDG-PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery. Int J Cancer 96 (2001) 191-197
170. Ricci P.E., Karis J.P., Heiserman J.E., et al. Differentiating recurrent tumor from radiation necrosis: Time for re-evaluation of positron emission tomography?. AJNR Am J Neuroradiol 19 (1998) 407-413
171. Kahn D., Follett K.A., Bushnell D.L., et al. Diagnosis of recurrent brain tumor: Value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET. AJR Am J Roentgenol 163 (1994) 1459-1465
172. Holzer T., Herholz K., Jeske J., et al. FDG-PET as a prognostic indicator in radiochemotherapy of glioblastoma. J Comput Assist Tomogr 17 (1993) 681-687
173. Tyler J.L., Diksic M., Villemure J.G., et al. Metabolic and hemodynamic evaluation of gliomas using positron emission tomography. J Nucl Med 28 (1987) 1123-1133
174. Rozental J.M., Levine R.L., Nickles R.J., et al. Glucose uptake by gliomas after treatment. A positron emission tomographic study. Arch Neurol 46 (1989) 1302-1307
175. Mineura K., Yasuda T., Kowada M., et al. Positron emission tomographic evaluation of radiochemotherapeutic effect on regional cerebral hemocirculation and metabolism in patients with gliomas. J Neurooncol 5 (1987) 277-285
176. Borgwardt L, Højgaard L, Carstensen H, et al: Fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography with magnetic resonance imaging co-registration is useful for monitoring hypermetabolic childhood brain tumors. Pediatr Blood Cancer (in press)
177. Botker H.E., Bottcher M., Schmitz O., et al. Glucose uptake and lumped constant variability in normal human hearts determined with [18F]fluorodeoxyglucose. J Nucl Cardiol 4 (1997) 125-132
178. Poulsen P.H., Smith D.F., Ostergaard L., et al. In vivo estimation of cerebral blood flow, oxygen consumption and glucose metabolism in the pig by [15O]water injection, [15O]oxygen inhalation and dual injections of [18F]fluorodeoxyglucose. J Neurosci Methods 77 (1997) 199-209
179. Kuwabara H., and Gjedde A. Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate. J Nucl Med 32 (1991) 692-698
180. Kuwabara H., Evans A.C., and Gjedde A. Michaelis-Menten constraints improved cerebral glucose metabolism and regional lumped constant measurements with [18F]fluorodeoxyglucose. J Cereb Blood Flow Metab 10 (1990) 180-189
181. Delbeke D., Meyerowitz C., Lapidus R.L., et al. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 195 (1995) 47-52
182. Meyer P.T., Schreckenberger M., Spetzger U., et al. Comparison of visual and ROI-based brain tumour grading using 18F-FDG-PET: ROC analyses. Eur J Nucl Med 28 (2001) 165-174
183. Brock C.S., Young H., O'Reilly S.M., et al. Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas. Br J Cancer 82 (2000) 608-615
184. Fulham M.J., Brunetti A., Aloj L., et al. Decreased cerebral glucose metabolism in patients with brain tumors: an effect of corticosteroids. J Neurosurg 83 (1995) 657-664
185. Herholz K., Holzer T., Bauer B., et al. 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 50 (1998) 1316-1322
186. Peet A.C., Leach M.O., Pinkerton C.R., et al. The development of functional imaging in the diagnosis, management and understanding of childhood brain tumours. Pediatr Blood Cancer 44 (2005) 103-113
187. Pauleit D., Floeth F., Hamacher K., et al. O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain 128 (2005) 678-687
188. Ishiwata K., Enomoto K., Sasaki T., et al. A feasibility study on L-[1-carbon-11]tyrosine and L-[methyl-carbon-11]methionine to assess liver protein synthesis by PET. J Nucl Med 37 (1996) 279-285
189. Hara T., Kosaka N., Shinoura N., et al. PET imaging of brain tumor with [methyl-11C]choline. J Nucl Med 38 (1997) 842-847
190. Shinoura N., Nishijima M., Hara T., et al. Brain tumors: Detection with C-11 choline PET. Radiology 202 (1997) 497-503
191. Del Sole A., Falini A., Ravasi L., et al. Anatomical and biochemical investigation of primary brain tumours. Eur J Nucl Med 28 (2001) 1851-1872
192. DeGrado T.R., Baldwin S.W., Wang S., et al. Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers. J Nucl Med 42 (2001) 1805-1814
193. Shields A.F., Grierson J.R., Dohmen B.M., et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med 4 (1998) 1334-1336
194. Mangner T.J., Klecker R.W., Anderson L., et al. Synthesis of 2′-deoxy-2′-[18F]fluoro-beta-D-arabinofuranosyl nucleosides, [18F]FAU, [18F]FMAU, [18F]FBAU and [18F]FIAU, as potential PET agents for imaging cellular proliferation. Synthesis of [18F]labelled FAU, FMAU, FBAU, FIAU. Nucl Med Biol 30 (2003) 215-224
195. Saleem A., Brown G.D., Brady F., et al. Metabolic activation of temozolomide measured in vivo using positron emission tomography. Cancer Res 63 (2003) 2409-2415
196. O'Tuama L.A., Treves S.T., Larar J.N., et al. Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: a within-subject comparison. J Nucl Med 34 (1993) 1045-1051
197. Maria B.L., Drane W.E., Mastin S.T., et al. Comparative value of thallium and glucose SPECT imaging in childhood brain tumors. Pediatr Neurol 19 (1998) 351-357
198. Rollins N.K., Lowry P.A., and Shapiro K.N. Comparison of gadolinium-enhanced MR and thallium-201 single photon emission computed tomography in pediatric brain tumors. Pediatr Neurosurg 22 (1995) 8-14
199. Maria B.L., Drane W.E., Quisling R.G., et al. Value of thallium-201 SPECT imaging in childhood brain tumors. Pediatr Neurosurg 20 (1994) 11-18
200. Maria B.L., Drane W.B., Quisling R.J., et al. Correlation between gadolinium-diethylenetriaminepentaacetic acid contrast enhancement and thallium-201 chloride uptake in pediatric brainstem glioma. J Child Neurol 12 (1997) 341-348
201. O'Tuama L.A., Poussaint T.Y., Anthony D.C., et al. Childhood brain tumor: Neuroimaging correlated with disease outcome. Pediatr Neurol 19 (1998) 259-262
202. O'Tuama L.A., Janicek M.J., Barnes P.D., et al. 201Tl/99mTc-HMPAO SPECT imaging of treated childhood brain tumors. Pediatr Neurol 7 (1991) 249-257
203. Ando A., Ando I., Katayama M., et al. Biodistributions of 201Tl in tumor bearing animals and inflammatory lesion induced animals. Eur J Nucl Med 12 (1987) 567-572
204. Kaplan W.D., Takvorian T., Morris J.H., et al. Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. J Nucl Med 28 (1987) 47-52
205. Schillaci O., Filippi L., Manni C., et al. Single-photon emission computed tomography/computed tomography in brain tumors. Semin Nucl Med 37 (2007) 34-47
206. Sun D., Liu Q., Liu W., et al. Clinical application of 201Tl SPECT imaging of brain tumors. J Nucl Med 41 (2000) 5-10
207. Carvalho P.A., Schwartz R.B., Alexander III E., et al. Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography. J Neurosurg 77 (1992) 565-570
208. Bagni B., Pinna L., Tamarozzi R., et al. SPET imaging of intracranial tumours with 99Tcm-sestamibi. Nucl Med Commun 16 (1995) 258-264
209. Maffioli L., Steens J., Pauwels E., et al. Applications of 99mTc-sestamibi in oncology. Tumori 82 (1996) 12-21
210. Maffioli L., Gasparini M., Chiti A., et al. Clinical role of technetium-99m sestamibi single-photon emission tomography in evaluating pretreated patients with brain tumours. Eur J Nucl Med 23 (1996) 308-311
211. O'Tuama L.A., Packard A.B., and Treves S.T. SPECT imaging of pediatric brain tumor with hexakis (methoxyisobutylisonitrile) technetium (I). J Nucl Med 31 (1990) 2040-2041
212. Kirton A., Kloiber R., Rigel J., et al. Evaluation of pediatric CNS malignancies with (99m)Tc-methoxyisobutylisonitrile SPECT. J Nucl Med 43 (2002) 1438-1443
213. Biersack H.J., Coenen H.H., Stocklin G., et al. Imaging of brain tumors with L-3-[123I]iodo-alpha-methyl tyrosine and SPECT. J Nucl Med 30 (1989) 110-112
214. Langen K.J., Ziemons K., Kiwit J.C., et al. 3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: A comparative study using SPECT and PET. J Nucl Med 38 (1997) 517-522
215. Langen K.J., Roosen N., Coenen H.H., et al. Brain and brain tumor uptake of L-3-[123I]iodo-alpha-methyl tyrosine: Competition with natural L-amino acids. J Nucl Med 32 (1991) 1225-1229
216. Reubi J.C., Lang W., Maurer R., et al. Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system. Cancer Res 47 (1987) 5758-5764
217. Krenning E.P., Kwekkeboom D.J., Bakker W.H., et al. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: The Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20 (1993) 716-731
218. Schmidt M., Scheidhauer K., Luyken C., et al. Somatostatin receptor imaging in intracranial tumours. Eur J Nucl Med 25 (1998) 675-686
219. Muller H.L., Fruhwald M.C., Scheubeck M., et al. A possible role for somatostatin receptor scintigraphy in the diagnosis and follow-up of children with medulloblastoma. J Neurooncol 38 (1998) 27-40
220. Chugani H.T., and Phelps M.E. Maturational changes in cerebral function in infants determined by 18FDG positron emission tomography. Science 231 (1986) 840-843
221. Thorngren-Jerneck K., Ohlsson T., Sandell A., et al. Cerebral glucose metabolism measured by positron emission tomography in term newborn infants with hypoxic ischemic encephalopathy. Pediatr Res 49 (2001) 495-501
222. Suhonen-Polvi H., Ruotsalainen U., Ahonen A., et al. Positron emission tomography in asphyxiated infants. Preliminary studies of regional cerebral glucose metabolism using 18F-FDG. Acta Radiol Suppl 376 (1991) 173
223. Lou H.C. Perinatal hypoxic-ischaemic brain damage and intraventricular haemorrhage. Baillieres Clin Obstet Gynaecol 2 (1988) 213-220
224. Muller R.A., Behen M.E., Rothermel R.D., et al. Brain organization for language in children, adolescents, and adults with left hemisphere lesion: A PET study. Prog Neuropsychopharmacol Biol Psychiatry 23 (1999) 657-668
225. O'Tuama L.A., Dickstein D.P., Neeper R., et al. Functional brain imaging in neuropsychiatric disorders of childhood. J Child Neurol 14 (1999) 207-221
226. Ernst M., Zametkin A.J., Matochik J.A., et al. High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder. Am J Psychiatry 156 (1999) 1209-1215
227. Lou H.C., Rosa P., Pryds O., et al. ADHD: increased dopamine receptor availability linked to attention deficit and low neonatal cerebral blood flow. Dev Med Child Neurol 46 (2004) 179-183
228. Delvenne V., Lotstra F., Goldman S., et al. Brain hypometabolism of glucose in anorexia nervosa: A PET scan study. Biol Psychiatry 37 (1995) 161-169
229. Delvenne V., Goldman S., Simon Y., et al. Brain hypometabolism of glucose in bulimia nervosa. Int J Eat Disord 21 (1997) 313-320
230. Castillo A.R., Buchpiguel C.A., de Araujo L.A., et al. Brain SPECT imaging in children and adolescents with obsessive-compulsive disorder. J Neural Transm 112 (2005) 1115-1129
231. Lee J.S., Juhasz C., Kaddurah A.K., et al. Patterns of cerebral glucose metabolism in early and late stages of Rasmussen's syndrome. J Child Neurol 16 (2001) 798-805
232. Fiorella D.J., Provenzale J.M., Coleman R.E., et al. (18)F-fluorodeoxyglucose positron emission tomography and MR imaging findings in Rasmussen encephalitis. AJNR Am J Neuroradiol 22 (2001) 1291-1299
233. Depas G., Chiron C., Tardieu M., et al. Functional brain imaging in HIV-1-infected children born to seropositive mothers. J Nucl Med 36 (1995) 2169-2174
234. Villemagne P.M., Naidu S., Villemagne V.L., et al. Brain glucose metabolism in Rett Syndrome. Pediatr Neurol 27 (2002) 117-122
235. Nielsen J.B., Friberg L., Lou H., et al. Immature pattern of brain activity in Rett syndrome. Arch Neurol 47 (1990) 982-986
236. Kaplan A.M., Chen K., Lawson M.A., et al. Positron emission tomography in children with neurofibromatosis-1. J Child Neurol 12 (1997) 499-506
237. Reed W., Jagust W., Al Mateen M., et al. Role of positron emission tomography in determining the extent of CNS ischemia in patients with sickle cell disease. Am J Hematol 60 (1999) 268-272
238. Kedar A., Drane W.E., Shaeffer D., et al. Measurement of cerebrovascular flow reserve in pediatric patients with sickle cell disease. Pediatr Blood Cancer (2005)
239. Worley G., Hoffman J.M., Paine S.S., et al. 18-Fluorodeoxyglucose positron emission tomography in children and adolescents with traumatic brain injury. Dev Med Child Neurol 37 (1995) 213-220